Amferia

Problem
Bacterial infections are likely to surpass cancer and heart disease as a number one cause of human deaths in the future with resistant bacteria and overuse of antibiotics.

Solution
A deeptech hydrogel patch where antimicrobial peptides punctures bacterial membranes and destroys the cells without harming surrounding tissue.

Potential
Faster and safer health for animals and humans making sure to fight unnecessary deaths so that more cab survive infections. All on a truly global market.

Amferia develops innovative medical devices to provide solutions to the global antibiotic resistance crisis. Amferia’s core focus is preventive healthcare where the goal is to provide highly efficient anti-infective medical devices that can prevent bacterial infections including those caused by antibiotic resistant bacteria. Our dominant focus is within the wound care sector, producing preventive care wound patches for the pressing need to avoid antibiotic resistant skin infections. Amferia’s proprietary anti-infective technology is a result of several years of research from Chalmers University of Technology and is patent protected.